Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02667249
Other study ID # ICP 001
Secondary ID
Status Completed
Phase N/A
First received December 8, 2015
Last updated January 25, 2016
Start date August 2011
Est. completion date June 2013

Study information

Verified date November 2015
Source University Hospital Tuebingen
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Observational

Clinical Trial Summary

Compliance to the clinical pathway, postoperative complication and total cost of the hospitalisation of patients undergoing elective cholecystectomy for symptomatic cholecystolithiasis were collected over two different periods: using a clinical pathway in form of a paper based check-list (group 1, n=118) or a clinical pathway integrated into the paper based medical treatment and nursing documentation (group 2, n=123). Outcome measures were compliance of the clinical pathway and total costs per case.


Description:

Data of patients undergoing elective cholecystectomy for symptomatic cholecystolithiasis were collected over two different periods: a clinical pathway in form of a paper based check-list (check-list group, n=118, or in form of a clinical pathway integrated into the paper based medical treatment and nursing documentation (integrated clinical pathway group, n=123. A standardized clinical pathway for elective laparoscopic cholecystectomy in form of a check list was initially established in 2008 and evaluated during a 6-month period (August 2011 until January 2012) at the University of Tuebingen. The integrated clinical pathway was evaluated during a 6-month period after an introduction phase of 2 months (November 2012 until April 2013). The contents of both clinical pathways were identical, especially concerning the standardization of perioperative fluid management, perioperative monitoring, nutrition, analgesia, reserve medications, preoperative and postoperative examinations, detailed laboratory blood testing, nursing standards and planned discharge.

Primary outcome measure was the compliance to the clinical pathway defined as an adherence of more than 80% to the presetted pathway items.


Recruitment information / eligibility

Status Completed
Enrollment 241
Est. completion date June 2013
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria:

- patients undergoing elective laparoscopic cholecystectomy

Exclusion Criteria:

- emergency procedures

- conversion to open cholecystectomy

Study Design

Observational Model: Case Control, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Other:
clinical pathway
implementation of a standardized clinical pathway

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Tuebingen

Outcome

Type Measure Description Time frame Safety issue
Primary compliance to clinical pathway Compliance to clinical pathway defined as an adherence of more than 80% to the presetted pathway items as reported on a paper based check-list time period which is covered by the clinical pathway beginning from preclinical check up until final discharge after cholecystctomy (usually a time frame of 7-14 days) No
Secondary complication Complications assessed according to Clavien classification 30 days postoperative 30 days complication rate Yes
Secondary total cost total costs per case covering the period from preclinical check up until final and discharge after cholecystctomy (€) were assessed using our prospective. electronic patient and quality assessment data base. Costs were calculated according to our internal transfer prices. total cost of the hospitalization covering the period from preclinical check up until final discharge after cholecystctomy (usually a time frame of 7-14 days) No
See also
  Status Clinical Trial Phase
Completed NCT01625026 - Obeticholic Acid in Bariatric and Gallstone Disease Phase 2
Completed NCT00530998 - Minimally Invasive Surgery: Using Natural Orfices
Completed NCT02858986 - 3D Versus 4K Laparoscopic Cholecystectomy N/A
Active, not recruiting NCT05592795 - Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
Terminated NCT02325492 - Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study Phase 2
Completed NCT02469935 - Accuracy of Surgeon-performed Ultrasound in Detecting Gallstones - a Validation Study N/A
Withdrawn NCT01232959 - Feasibility of Transvaginal Cholecystectomy N/A
Completed NCT01190280 - Indications for Gallbladder Surgery in Gallstone Disease Phase 3
Withdrawn NCT00460980 - Effect of Virtual Reality Training by Novices on Laparoscopic Cholecystectomy in a Porcine Model N/A
Completed NCT02344654 - Fluorescence Cholangiography During Cholecystectomy - a RCT N/A
Completed NCT00528632 - Gallbladder Cholesterolosis, Body Mass Index and Serum Cholesterol and Triglycerides N/A
Recruiting NCT03891147 - A Clinical Trial of Electro-acupuncture for Treating Gallstone Diseases N/A
Not yet recruiting NCT06385860 - Prediction Model for Early Biliary Stasis After Bariatric Surgery
Completed NCT02831556 - Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Completed NCT02947256 - Laparoscopic Cholecystectomy With Retro-infundibular Approach Phase 2
Recruiting NCT01438385 - Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders N/A
Completed NCT01410734 - Fluorescence Imaging on the da Vinci Surgical System for Intra-operative Near Infrared Imaging of the Biliary Tree (up to 2-weeks Post-operatively) N/A
Withdrawn NCT00240123 - Effect of Benadryl Sedation During ERCP or EUS Phase 1
Completed NCT03809559 - Repeatability and Reproducibility of Quantitative MRCP
Recruiting NCT01822262 - Contrastive Study for Minimally Invasive Cholecystolithotomy With Gallbladder Reservation and Laparoscopic Cholecystectomy Phase 4